We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Warns California Compounder for Unapproved Drugs Following Patient Death
FDA Warns California Compounder for Unapproved Drugs Following Patient Death
Drug compounder ImprimisRx landed itself in hot water with the FDA for producing adulterated, misbranded and unapproved drug products at its Irvine, California facility, activity that prompted the FDA to issue the firm a warning letter.